Mesothelioma Doctors / Physicians
Robert N. Taub, M.D.
- Title
- Professor of Clinical Medicine, Columbia University College of Physicians and Surgeons/New York Presbyterian Hospital, New York, NY
- Phone
- (212) 659-6815
- Education
- A.B. - Magna Cum Laude, Yeshiva University, 1957
M.D. - Yale University School of Medicine, 1961
Ph.D. - London University, 1969. Zoology
- Fellowship
- Yale University School of Medicine
- Board Certifications
-
- Allergy & Immunology
- Hematology
- Internal Medicine
- Oncology
- Clinical
Expertise
-
- Chemotherapy
- Anemia
- Leukemia
- Website
- Biography/CV
(will open new window)
Dr. Robert N. Taub is a leader in the field of mesothelioma research and
medical techniques. He is the Professor of Clinical Medicine at Columbia
University, College of Physicians and Surgeons, and a medical oncologist who
directs the Connective Tissue Oncology Program at the Herbert Irving
Comprehensive Cancer Center, where there are several ongoing multimodality
studies of patients with pleural and peritoneal mesothelioma. He has been
developing a highly effective technique involving combinations of
chemotherapy with surgery.
Dr. Taub also serves on the Science Advisory Board of the Mestohelioma
Applied Research Foundation (MARF). MARF is a non-profit organization
dedicated to stopping mesothelioma as a life-ending disease.
His work has been recognized and awarded by the Israel Cancer Research Fund,
the Mount Sinai Hospital and the American Cancer Society.
Dr. Robert Taub has been published in several medical publications including
Biochemistry, Seminars in Oncology, Seminars in Thoracic and Cardiovascular
Surgery, and Current Therapy in Cancer.
Dr. Taub has served the medical community for more than 40 years in the
areas of medical oncology, immunology, hematology, and internal medicine.
Highlights of his career include:
- Director, Inpatient Medical Oncology Unit, Columbia Presbyterian Medical
Center, New York, NY, 1985-91
- Deputy Director for Clinical Research and Patient Care, Columbia University
Comprehensive Cancer Center, New York, NY, 1989-91
- Co-Director, Columbia University Comprehensive Cancer Center, New York, NY.
1981- 84
- Deputy Director for Cancer Control, Columbia University Comprehensive Cancer
Center, New York, NY, 1981-89
- Professor of Internal Medicine and Microbiology; Chairman, Division of
Medical Oncology; Chief Attending Oncologist. Medical College of Virginia,
Richmond, VA, 1976-81
- American Cancer Society Professor of Clinical Oncology, 1977-81
- Associate Director for Clinical Affairs, MCV-VCU Cancer Center, Richmond,
VA, 1977-81
- Associate Professor of Medicine, Mount Sinai School of Medicine, Associate
Attending Physician, Mount Sinai Hospital, New York, 1973-76
- Director, Transplantation Immunology Laboratory, Departments of Medicine and
Surgery, Mount Sinai Hospital, New York, 1970-76
- Assistant Professor of Medicine, Mount Sinai School of Medicine and
Assistant Attending Physician (Hematology, Mount Sinai Hospital, New York,
1969-73
- Associate in Medicine and Hematology, Mount Sinai Hospital School of
Medicine, New York, 1968-69
- Research Fellowship (Immunology), National Institute for Medical Research at
Mill Hill, London, England, 1968-69
- Assistant Residency, Internal Medicine, New England Medical Center Hospital,
Boston, Massachusetts, 1965-66
- Clinical and Research Fellowship, Hematology, Blood Research Laboratory, New
England Medical Center Hospital, Boston, Massachusetts, 1963-65
- Internship and Research Fellowship, Pathology. Yale University School of
Medicine. New Haven Connecticut, 1962-63
- Internship, Medical Service. New England Medical Center Hospital, Boston,
Massachusetts, 1961-62
|
|
Mesothelioma is a serious cancer that
occurs in individuals exposed to
asbestos. 
